A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients
Clinical trial NCT01567540 · TERMINATED
Trial details
- NCT number
- NCT01567540
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.